Skip to main content

Articles

Page 4 of 336

  1. Gliomas are the deadliest malignant tumors of the adult central nervous system. We previously discovered that beta2-microglobulin (B2M) is abnormally upregulated in glioma tissues and that it exerts a range of...

    Authors: Zhen-Yuan Liu, Feng Tang, Jing Wang, Jin-Zhou Yang, Xi Chen, Ze-Fen Wang and Zhi-Qiang Li
    Citation: BMC Cancer 2024 24:692
  2. Multicenter non-small cell lung cancer (NSCLC) patient data is information-rich. However, its direct integration becomes exceptionally challenging due to constraints involving different healthcare organization...

    Authors: Yuan Liu, Jinzao Huang, Jyh-Cheng Chen, Wei Chen, Yuteng Pan and Jianfeng Qiu
    Citation: BMC Cancer 2024 24:688
  3. Background The methylation of SHOX2 and RASSF1A shows promise as a potential biomarker for the early screening of lung cancer, offering a solution to remedy the limitations of morphological diagnosis. The aim of ...

    Authors: Jiaping Zhao, Yu Lu, Xiaosha Ren, Tingting Bian, Jia Feng, Hui Sun, Lei Liu, Bin She, Yifei Liu and Honggang Ke
    Citation: BMC Cancer 2024 24:687
  4. Primary tracheal tumors are very rare and their management is not definitely established. Due to its rarity, providing patient care in terms of optimal management poses a considerable challenge. The purpose of...

    Authors: Aleksandra Piórek, Adam Płużański, Magdalena Knetki-Wróblewska, Kinga Winiarczyk, Sylwia Tabor, Paweł Teterycz, Dariusz M. Kowalski and Maciej Krzakowski
    Citation: BMC Cancer 2024 24:686
  5. Gastric cancer is one of the most common tumors worldwide, and most patients are deprived of treatment options when diagnosed at advanced stages. PRDM14 has carcinogenic potential in breast and non-small cell ...

    Authors: Xiao Li, Cong Wang, Youcai Wang, Xiaobing Chen, Zhi Li, Jianwei Wang and Yingjun Liu
    Citation: BMC Cancer 2024 24:685
  6. Many randomized controlled trials (RCTs) and network meta-analyses have demonstrated that the progression-free survival (PFS) and overall survival (OS) of advanced non-small cell lung cancer (NSCLC) patients c...

    Authors: Wen Hui, Wentan Li, Ruomeng Song, Yu Xin, Changjin Wu, Zhixiang Gao, Mingyue Zhang, Huazhang Wu, Min Zhu and Yuanyi Cai
    Citation: BMC Cancer 2024 24:684
  7. MicroRNAs (miRNAs) emerge in various organisms, ranging from viruses to humans, and play crucial regulatory roles within cells, participating in a variety of biological processes. In numerous prediction method...

    Authors: Hou Biyu, Li Mengshan, Hou Yuxin, Zeng Ming, Wang Nan and Guan Lixin
    Citation: BMC Cancer 2024 24:683
  8. Our previous studies have indicated that mRNA and protein levels of PPIH are significantly upregulated in Hepatocellular Carcinoma (LIHC) and could act as predictive biomarkers for patients with LIHC. Nonetheless...

    Authors: Jun Ye, Jianchao Ying, Haixia Chen, Zhiping Wu, Chaolin Huang, Chuan Zhang, Zhitao Chen and Haini Chen
    Citation: BMC Cancer 2024 24:681
  9. To evaluate the feasibility, safety and efficacy of concurrent simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) combined with nimotuzumab in the treatment of locally advanced esophagea...

    Authors: Lan Wang, Lihong Liu, Yu Cao, Xiaoxi Chen, Shutang Liu, Xiaoning Li, Jing Han, Qi Wang and Chun Han
    Citation: BMC Cancer 2024 24:679
  10. Despite several preventative and control measures Ethiopia continues to see an increase in cervical cancer. Comprehensive evidence is very important to suggest ministry of health. Therefore, the aim of this st...

    Authors: Yeshiwas Ayale Ferede, Worku Chekol Tassew and Agerie Mengistie Zeleke
    Citation: BMC Cancer 2024 24:678
  11. Mortality benefit of transfusion with leucoreduced whole blood has not been demonstrated in the sub-Saharan Africa (SSA). We compared mortality in patients with cancer transfused with leucoreduced and non-leuc...

    Authors: Clement D. Okello, Jackson Orem, Martin Nabwana, Noah Kiwanuka, Andrew W. Shih, Nancy Heddle and Harriet Mayanja-Kizza
    Citation: BMC Cancer 2024 24:677
  12. Circulating total insulin-like growth factor-I (IGF-I) is an established risk factor for prostate cancer. However, only a small proportion of circulating IGF-I is free or readily dissociable from IGF-binding p...

    Authors: Tuck Seng Cheng, Urwah Noor, Eleanor Watts, Michael Pollak, Ye Wang, James McKay, Joshua Atkins, Giovanna Masala, Maria-Jose Sánchez, Antonio Agudo, Jesús Castilla, Dagfinn Aune, Sandra M. Colorado-Yohar, Luca Manfredi, Marc J. Gunter, Valeria Pala…
    Citation: BMC Cancer 2024 24:676
  13. Merkel cell carcinoma (MCC) is a rare but aggressive neuroendocrine tumour of the skin with poor prognosis and rising global incidence. A recently published article in BMC Cancer, titled “Merkel cell carcinoma...

    Authors: James Leigh and Kurt Gebauer
    Citation: BMC Cancer 2024 24:675
  14. Colorectal cancer is the leading cause of cancer death worldwide. The first and second lines of treatment for metastatic colorectal cancer (mCRC) include chemotherapy based on 5-fluorouracil. However, treatmen...

    Authors: Francisco Cezar Aquino de Moraes, Felipe Dircêu Dantas Leite Pessôa, Caio Henrique Duarte de Castro Ribeiro, Marianne Rodrigues Fernandes, Rommel Mario Rodríguez Burbano and Ney Pereira Carneiro dos Santos
    Citation: BMC Cancer 2024 24:674
  15. Hepatocellular carcinoma (HCC) genomic research has discovered actionable genetic changes that might guide treatment decisions and clinical trials. Nonetheless, due to a lack of large-scale multicenter clinica...

    Authors: Mengqi Song, Haoyue Cheng, Hao Zou, Kai Ma, Lianfang Lu, Qian Wei, Zejiang Xu, Zirui Tang, Yuanzheng Zhang, Yinan Wang and Chuandong Sun
    Citation: BMC Cancer 2024 24:673
  16. Patients with primary multifocal hepatocellular carcinoma (HCC) have a poor prognosis and often experience a high rate of treatment failure. Multifocal HCC is mainly caused by intrahepatic metastasis (IM), and...

    Authors: Weilong Zou, Zhanjie Fang, Yu Feng, Shangjin Gong, Ziqiang Li, Meng Li, Yong Sun, Xiuyan Ruan, Xiangdong Fang, Hongzhu Qu and Haiyang Li
    Citation: BMC Cancer 2024 24:672
  17. The role of novel circular RNAs (circRNAs) in colorectal cancer (CRC) remains to be determined. This study aimed to identify a novel circRNA involved in CRC pathogenesis, assess its diagnostic value, and const...

    Authors: Ke-zhi Li, Xiao-min Liao, Si-qi Li, Hao-tang Wei, Zhi-jian Liang, Liu-xin Ge, Su-fang Zhou and Bang-li Hu
    Citation: BMC Cancer 2024 24:671
  18. An accurate and non-invasive approach is urgently needed to distinguish tuberculosis granulomas from lung adenocarcinomas. This study aimed to develop and validate a nomogram based on contrast enhanced-compute...

    Authors: Liping Yang, Zhiyun Jiang, Jinlong Tong, Nan Li, Qing Dong and Kezheng Wang
    Citation: BMC Cancer 2024 24:670
  19. Cancer has become a major health concern due to the increasing morbidity and mortality rates, and its negative social, economic consequences and the heavy financial burden incurred by cancer patients. About 40...

    Authors: Mohamed Khalis, Imad Elbadisy, Oumnia Bouaddi, Amy Luo, Amina Bendriouich, Badr Addahri, Hafida Charaka, Mohamed Chahboune, Jérôme Foucaud, Abdallah Badou, Lahcen Belyamani and Inge Huybrechts
    Citation: BMC Cancer 2024 24:669
  20. Gastrointestinal cancers represent one of the most prevalent diseases worldwide. Strikingly, the incidence of Early Onset Gastrointestinal Cancer (EOGIC) has been rising during the last decades and changes in ...

    Authors: R. Vera, N. Castro, I. Labiano, A. Lecumberri, A. E. Huerta, H. Arasanz, I. Caseda, F. Ruiz-Pace, C. Viaplana, V. Arrazubi, I. Hernandez-Garcia, E. Mata, D. Gomez, S. Laguna, J. Suarez, I. Fernandez-De-los-Reyes…
    Citation: BMC Cancer 2024 24:668

    The Correction to this article has been published in BMC Cancer 2024 24:819

  21. The causal impact of lipid-lowering drugs on ovarian cancer (OC) and cervical cancer (CC) has received considerable attention, but its causal relationship is still a subject of debate. Hence, the objective of ...

    Authors: Jinshuai Li, Zixian Yang, Tao Wang, Mengqi Li, Xiangjian Wu, Xiaoyan Fu, Chunfeng Yang, Yangpu Li, Ximing Wang, Zhiming Lan, Minfang Li and Sheng Chen
    Citation: BMC Cancer 2024 24:667
  22. Currently, there is no consensus on the treatment of recurrent hepatocellular carcinoma (HCC) after hepatectomy. It is necessary to assess the efficacy and safety of radiofrequency ablation (RFA) combined with...

    Authors: Fei Cao, Jiaping Zheng and Weiyuan Hao
    Citation: BMC Cancer 2024 24:666
  23. Recent studies have shown that blue light-emitting diode (LED) light has anti-tumor effects, suggesting the possibility of using visible light in cancer therapy. However, the effects of blue light irradiation ...

    Authors: Toshiaki Yoshimoto, Masaaki Nishi, Shohei Okikawa, Kozo Yoshikawa, Takuya Tokunaga, Toshihiro Nakao, Chie Takasu, Hideya Kashihara, Yuma Wada, Takayuki Noma and Mitsuo Shimada
    Citation: BMC Cancer 2024 24:664
  24. Death anxiety is thought to cause a range of mental disorders among cancer patients, which may affect their mental health and even quality of life. This study sought to investigate experiential avoidance, mean...

    Authors: Yixia Yan, Yongyi Chen, Meijun Ou, Youwen Gong, Renting Yang, Xiangyu Liu, Wanting Xia, Furong Chen, Hongling Zheng and Xianghua Xu
    Citation: BMC Cancer 2024 24:663
  25. Despite increased use of immune checkpoint inhibitors (ICIs) in patients with advanced melanoma, little is known about patient experiences during this treatment. This study aimed to gain an in-depth understand...

    Authors: Nadia C.W. Kamminga, Astrid A.M. van der Veldt, Marlies Wakkee, Fauve R. van den Berge, Lianne A.A. van der Beek, Margot C.W. Joosen, Arjen Joosse, Karlijn de Joode, Tamar E.C. Nijsten and Marjolein Lugtenberg
    Citation: BMC Cancer 2024 24:662
  26. In the era of targeted therapies, the influence of aging on cancer management varies from one patient to another. Assessing individual frailty using geriatric tools has its limitations, and is not appropriate ...

    Authors: Mélanie Casile, Gilles Albrand, Clément Lahaye, Benjamin Lebecque, Joévin Besombes, Céline Bourgne, Bruno Pereira, Sandrine Saugues, Caroline Jamot, Eric Hermet and Marc G. Berger
    Citation: BMC Cancer 2024 24:661

    The Correction to this article has been published in BMC Cancer 2024 24:806

  27. Breast and cervical cancer are the two leading cancers in terms of incidence and mortality. Previous studies reported different interleukins, including interleukin-17A (IL-17A) to be responsible for the developme...

    Authors: Md. Abdul Aziz, Subrina Chowdhury, Sarah Jafrin, Md Abdul Barek, Mohammad Sarowar Uddin, Md. Shalahuddin Millat and Mohammad Safiqul Islam
    Citation: BMC Cancer 2024 24:660
  28. To investigate the diagnostic efficacy of high-frame-rate contrast-enhanced ultrasound (H-CEUS) in differentiating between clear cell renal cell carcinoma (CCRCC) and angiomyolipoma (AML).

    Authors: JingLing Wang, JiaYu Shi, Long Gao, WeiHong Hu, Miao Chen and WeiPing Zhang
    Citation: BMC Cancer 2024 24:659
  29. Adherence to chemotherapy treatment is recognized as a crucial health concern, especially in managing cancer patients. Chemotherapy presents challenges for patients, as it can lead to potential side effects th...

    Authors: Amineh Rashidi, Susma Thapa, Wasana Sandamali Kahawaththa Palliya Guruge and Shubhpreet Kaur
    Citation: BMC Cancer 2024 24:658
  30. The aim is to establish and verify reference intervals (RIs) for serum tumor markers for an apparently healthy elderly population in Southwestern China using an indirect method.

    Authors: Qiang Miao, Shuting Lei, Fengyu Chen, Qian Niu, Han Luo and Bei Cai
    Citation: BMC Cancer 2024 24:657
  31. This study aims to compare treatment outcomes between neoadjuvant chemotherapy (NACT) followed by surgery and concurrent chemoradiotherapy (CCRT) in patients with stage IIB cervical squamous cell carcinoma (CS...

    Authors: Xin-Bin Pan, Yan Lu, You-Sheng Wei and De-Sheng Yao
    Citation: BMC Cancer 2024 24:655
  32. Immune checkpoint inhibitors (ICIs) have demonstrated superior clinical efficacy in prolonging overall survival (OS) as the second-line treatment for advanced or metastatic esophageal squamous cell carcinoma (...

    Authors: Xiuli Yang, Xiaochun Zheng, Sang Hu, Jinlong Huang, Miaomiao Zhang, Ping Huang and Jiangfeng Wang
    Citation: BMC Cancer 2024 24:654
  33. Pancreatic cancer, a highly fatal malignancy, has shown a global rise in the incidence and mortality rates. However, these rates vary significantly across different regions worldwide. This study aims to assess...

    Authors: Nasr Eldin Elwali, Saad Mohammed AlShareef, Ammar H. Khamis and Moawia M. A. Elhassan
    Citation: BMC Cancer 2024 24:653
  34. Pancreatic ductal adenocarcinoma (PDAC) ranks among the deadliest types of cancer, and it will be meaningful to search for new biomarkers with prognostic value to help clinicians tailor therapeutic strategies.

    Authors: Xiwen Chen, Linying Chen, Jikui Miao, Xingxin Huang, Xiahui Han, Liqin Zheng, Shuoyu Xu, Jianxin Chen and Lianhuang Li
    Citation: BMC Cancer 2024 24:652
  35. This study aimed to explore the effect of CD276 expression on the sunitinib sensitivity of clear cell renal cell carcinoma (ccRCC) cell and animal models and the potential mechanisms involved.

    Authors: Zhi-yu Zhang, Jian-hao Xu, Jiang-lei Zhang, Yu-xin Lin and Jun Ou-Yang
    Citation: BMC Cancer 2024 24:650
  36. Neoadjuvant immune checkpoint blockade (ICB) combined with chemoradiotherapy offers high pathologic complete response (pCR) rate for patients with locally advanced esophageal squamous cell carcinomas (ESCC). B...

    Authors: Dan-Dan Zheng, Yu-Ying Li, Xiao-Yi Yuan, Jiang-Li Lu, Mei-Fang Zhang, Jia Fu and Chris Zhiyi Zhang
    Citation: BMC Cancer 2024 24:649
  37. This study aimed to assess the long-term effect of level IIb clinical target volume (CTV) optimisation on survival, xerostomia, and dysphagia in patients with nasopharyngeal carcinoma (NPC).

    Authors: Jiawei Zhou, Li Wang, Ting Qiu, Han Gao, Lijun Wang, Shengfu Huang, Xia He and Lirong Wu
    Citation: BMC Cancer 2024 24:648
  38. Patient satisfaction is an important indicator of the quality of healthcare. Pain is one of the most common symptoms among cancer patients that needs optimal treatment; rather, it compromises the quality of li...

    Authors: Molla Amsalu, Henos Enyew Ashagrie, Amare Belete Getahun and Yophtahe Woldegerima Berhe
    Citation: BMC Cancer 2024 24:647
  39. Radiotherapy interruption (RTI) prolongs the overall total treatment time and leads to local control loss in many cancers, but it is unclear in esophageal cancer. We aimed to evaluate the influence of RTI on t...

    Authors: Yanhong Mou, Peng Liang, Xun Cheng, Xin He, Jun Zhang, Liangzhong Liu and Qiang Liu
    Citation: BMC Cancer 2024 24:646
  40. Cerebellar degeneration-related (CDR) proteins are associated with paraneoplastic cerebellar degeneration (PCD) – a rare, neurodegenerative disease caused by tumour-induced autoimmunity against neural antigens...

    Authors: Eirik Tveit Solheim, Yola Gerking, Torbjørn Kråkenes, Ida Herdlevær, Even Birkeland, Cecilie Totland, Fiona Dick and Christian Alexander Vedeler
    Citation: BMC Cancer 2024 24:645
  41. Understanding the metabolic changes in colorectal cancer (CRC) and exploring potential diagnostic biomarkers is crucial for elucidating its pathogenesis and reducing mortality. Cancer cells are typically deriv...

    Authors: Xuancheng Wang, Xuan Guan, Ying Tong, Yunxiao Liang, Zongsheng Huang, Mingsen Wen, Jichu Luo, Hongwei Chen, Shanyi Yang, Zhiyong She, Zhijuan Wei, Yun Zhou, Yali Qi, Pingchuan Zhu, Yanying Nong and Qisong Zhang
    Citation: BMC Cancer 2024 24:644
  42. The proposed trial is to examine the feasibility of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT)-guided cytoreduction plus apalutamide and androgen depriv...

    Authors: Beihe Wang, Jian Pan, Tingwei Zhang, Xudong Ni, Yu Wei, Xiaomeng Li, Bangwei Fang, Xiaoxin Hu, Hualei Gan, Junlong Wu, Hongkai Wang, Dingwei Ye and Yao Zhu
    Citation: BMC Cancer 2024 24:643
  43. PD-L1 was an important biomarker in lung adenocarcinoma. The study was to confirm the most important factor affecting the expression of PD-L1 remains undetermined.

    Authors: Fang Lu, Ernuo Wang and Haiquan Liu
    Citation: BMC Cancer 2024 24:642
  44. Pediatric Acute Myeloid Leukemia (AML) is a major cause of morbidity and mortality in children with cancer in Africa and other developing continents. Systemic chemotherapy and effective supportive care have si...

    Authors: Wudinesh Mamo, Ayalew Moges, Subah Abderehim Yesuf, Abdulkadir Mohamedsaid and Gashaw Arega
    Citation: BMC Cancer 2024 24:640
  45. Brachytherapy has been indicated as an alternative option for treating cystic craniopharyngiomas (CPs). The potential benefits of brachytherapy for CPs have not yet been clarified. The purpose of this work was...

    Authors: Li-Yuan Zhang, Wei Guo, Han-Ze Du, Hui Pan, Yun-Chuan Sun, Hui-Juan Zhu, Shuai-Hua Song, Xiao-Yuan Guo, Yue Jiang and Qian-Qian Sun
    Citation: BMC Cancer 2024 24:637

Featured videos

View featured videos from across the BMC-series journals